News Briefs
  • 9:52

    Anar Otolangi, 34, is first participant in Hadassah vaccine trial

    Anar Otolangi, a 34-year-old resident of the south, received the vaccine developed at the Biological Institute at Hadassah Ein Kerem Hospital.

    "I feel well, a little excited, and encourage as many people as possible to join the experiment and help the entire public," he said.